Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada

Can Respir J. 2010 Mar-Apr;17(2):57-60. doi: 10.1155/2010/378289.

Authors

M Diane Lougheed¹, Catherine Lemiere, Sharon Dell, Francine Ducharme, J Mark Fitzgerald, Richard Leigh, Chris Licskai, Brian H Rowe, Dennis Bowie, Allan Becker, Louis-Philippe Boulet

Affiliation

¹ Department of Medicine, Queen's University, Kingston, Ontario, Canada. mdl@queensu.ca

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adrenergic beta-2 Receptor Agonists / adverse effects*
Adrenergic beta-2 Receptor Agonists / therapeutic use*
Adult
Age Factors
Asthma / drug therapy*
Canada
Child
Delayed-Action Preparations
Humans
Societies, Medical
United States
United States Food and Drug Administration
Young Adult

Substances

Adrenergic beta-2 Receptor Agonists
Delayed-Action Preparations